In 2023, RIVM will take systematic measurements of ultrafine particles in the outside air for the first time. This is necessary because little is known at present about ultrafine particles and their potential health effects. Ultrafine particles must be measured with different equipment than that usually used for particulate matter.

From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.

In 2022, the European Commission introduced a proposal for stricter air quality standards. With existing policy measures, the air quality in most of the Netherlands will meet these requirements by 2030.

RIVM expects the air quality to be poor or very poor for a brief period over Easter, particularly in areas where Easter fires are lit. This is because the burning of wood leads to high local concentrations of particulate matter in the air. These high concentrations may cause health problems. People affected by these problems are advised to avoid strenuous physical activity.

From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.

In 2021, greenhouse gas emissions were 1.8% higher than the year before. This marked the first time emissions had gone up since 2016. In 2020, emissions declined by 8.8%. The 2021 increase is largely attributable to CO2 and to the cold winter.

In 2021, the Netherlands once again met the European limit values for nitrogen dioxide emitted at ground-level by road traffic. This was also the case for particulate matter along the roads, with the exception of a small stretch of road near Velsen.

Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.

From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.

Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.